Skip to content

Achieve Life Sciences ACHV Increase Decrease In Lease Obligations

Increase Decrease In Lease Obligations at other companies

Aeva Technologies logo
Aeva TechnologiesAEVA
-$437K+54.0%
Mannkind logo
MannkindMNKD
-$939K+3.4%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
-$2.18M-692%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$681K+833%
Assembly Biosciences logo
Assembly BiosciencesASMB
-$202K-38.4%
Annexon logo
AnnexonANNX
-$767K-15.5%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept achv:IncreaseDecreaseInLeaseObligations.

The official record: Achieve Life Sciences’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's increase decrease in lease obligations.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's increase decrease in lease obligations?
Achieve Life Sciences (ACHV) reported increase decrease in lease obligations of -$1K in Q4 2025.
What does increase decrease in lease obligations mean?
Represents the net change in lease-related liabilities, reflecting the cash impact of lease payments versus recognized rent expense. It is a key indicator of the company's fixed operational commitments and long-term facility obligations.